google-site-verification=yzG5X3wSoDwFeTsfDRRdFEScjS08yrFdZp86XRKWads



TRICARE Formulary Change

National VFW - 5/12/2017

Nexium, a popular drug used to treat gastroesophageal reflux disease, will be removed from TRICARE's formulary list. Effective June 28, 2017, the drug will no longer be available in military hospitals and clinics and those patients who choose to remain on the drug will pay increased fees. The change comes because the drug's producer, biopharmaceutical company AstraZeneca, cancelled the Department of Defense's 10-year Nexium preferred pricing agreement on April 1. The increased price is costing the DOD an additional $1.6 million per day. The almost 338,000 TRICARE patients currently prescribed Nexium are advised to contact their doctors to determine if Nexium is medically necessary or if they can safely be switched to an alternative drug. Patients taking Nexium should receive letters from the Defense Health Agency with more details. Read more about alternatives and costs.

Post News

Important Info for Post1393 Members

VFW News and Publications

Newsletter coming soon!

Statewide News

News & Info from your department

January 7th at 6:00 pm CT - War Memorial Center - Medicating Normal

January 7th at 6:00 pm CT - War Memorial Center for a virtual community screening of Medicating Normal

FY2021 VFW POST PANDEMIC RELIEF GRANT

Eligibility Requirement Updates – December 2020

National News

Important info from National VFW

VFW to Host #SportClipsSalute Week

KANSAS CITY, Mo. - The Veterans of Foreign Wars (VFW) is encouraging its more than 1.5 million VFW and Auxiliar...

Post of the Month Launches to Showcase How Posts Are #StillServing

The VFW is proud to honor all veterans who are #StillServing, and it's especially meaningful to see the ways Posts have provided much needed assist...